Compounds > n,n-dimethyl-n-hexadecyl-1-octadecylammonium
Page last updated: 2024-09-04

n,n-dimethyl-n-hexadecyl-1-octadecylammonium and Lung Diseases, Interstitial

n,n-dimethyl-n-hexadecyl-1-octadecylammonium has been researched along with Lung Diseases, Interstitial in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hata, T; Hiraki, M; Hori, A; Ikeshima, R; Katsuyama, S; Kikumori, K; Masuzawa, T; Mitsuyoshi, A; Murata, K; Ohmura, Y; Oshima, K; Shinke, G; Sugimura, K; Takeda, Y; Yanagawa, T1

Other Studies

1 other study(ies) available for n,n-dimethyl-n-hexadecyl-1-octadecylammonium and Lung Diseases, Interstitial

ArticleYear
[A Case of Drug-Induced Interstitial Pneumonia after Dose-Dense AC Therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2022, Volume: 49, Issue:13

    Topics: Aged; Breast Neoplasms; Doxorubicin; Female; Humans; Lung Diseases, Interstitial; Paclitaxel

2022